Form 8-K ARC Group Securities For: Oct 20
http://archive.fast-edgar.com/20261023/AQ24622CZZ2RV2RZ2K9S2MY2EB8CZZ22Z282
Filed on: October 23, 2026
Form 8-K ACADIA PHARMACEUTICALS For: Oct 23
0001070494false00010704942026-10-232026-10-23
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 23, 2026
Acadia Pharmaceuticals Inc.
(Exact name of Registrant as Specified in Its Charter)
Form 13F-HR Total Wealth Planning & For: Sep 30
.FormData {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
}
.FormDataC {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align: center;
}
.FormDataR {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align:... (continue reading...)
Form DEF 14A Marpai, Inc. For: Dec 09
DEF 14A
false
0001844392
0001844392
2024-01-01
2024-12-31
0001844392
2025-01-01
... (continue reading...)
Form 424B2 BofA Finance LLC
This pricing supplement, which is not complete and may be changed, relates to an effective Registration Statement under the Securities Act of 1933. This pricing supplement and the accompanying product supplement, prospectus supplement and prospectus are not an offer to sell these notes in any country or jurisdiction where such an offer would not be permitted.
... (continue reading...)More SEC Filings
View Older Stories-
Form 8-K Picard Medical, Inc. For: Oct 20
-
Form 4 Robinhood Ventures Fund For: Oct 21 Filed by: Robinhood Markets, Inc.
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 13F-HR Revolve Wealth Partners, For: Sep 30
-
Form 4 Hewlett Packard Enterpri For: Oct 21 Filed by: rahim rami
-
Form 4 Allogene Therapeutics, For: Oct 21 Filed by: Parker Geoffrey M.
-
Form 13F-HR Orange Investment Adviso For: Sep 30
-
Form DEF 14A Tenaya Therapeutics, For: Dec 09
-
Form 485BPOS Zacks Trust
-
Form 8-K Allegiant Travel CO For: Oct 19
-
Form D/A Tech (plus) Bio Fund I,
-
Form DEF 14C Venerable Variable Insur For: Mar 10
-
Form 4 Arcosa, Inc. For: Oct 23 Filed by: Cole Kerry S
-
Form 13F-HR Beacon Capital Managemen For: Sep 30
-
Form 4 Arcosa, Inc. For: Oct 23 Filed by: DEMETRIOU STEVEN J.
-
Form 4 Arcosa, Inc. For: Oct 23 Filed by: Carrillo Antonio
-
Form 4 Arcosa, Inc. For: Oct 23 Filed by: Peck Gail M
-
Form 4 Arcosa, Inc. For: Oct 23 Filed by: LINDSAY JOHN W
-
Form 4 Arcosa, Inc. For: Oct 23 Filed by: BEST RHYS J
-
Form 4 Arcosa, Inc. For: Oct 23 Filed by: Hurst Eric D
-
Form 4 Arcosa, Inc. For: Oct 23 Filed by: ALVARADO JOSEPH
-
Form 4 Arcosa, Inc. For: Oct 23 Filed by: Lubel Kimberly S
-
Form 8-K Energy Services of Ameri For: Oct 23
-
Form 4 Arcosa, Inc. For: Oct 23 Filed by: Trent Melanie Montague
-
Form RW Robinhood Ventures Fund
-
Form 4 Arcosa, Inc. For: Oct 23 Filed by: PIGGOTT JULIE A
-
Form 4 Arcosa, Inc. For: Oct 23 Filed by: Stevenson Bryan
-
Form 4 Arcosa, Inc. For: Oct 23 Filed by: Essl Reid S
-
Form 4 Arcosa, Inc. For: Oct 23 Filed by: Craig Jeffrey A
-
Form 8-K FIRST CAPITAL INC For: Oct 23
-
Form 144 EQUIFAX INC Filed by: Mao Cecilia
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 13F-HR Split Creek LLC DBA Spli For: Dec 31
-
Form D Otro M Co-Investment,
-
Form D Bloom Stack Corp.
-
Form 13F-HR Michael Brady & Co., For: Sep 30
-
Form 485BXT FIS Trust
-
Form DEFM14A Blue Acquisition Corp/Ca
-
Form N-30B-2 CALIFORNIA FIRST LEASING For: Sep 30
-
Form 8-K Ardent Health, Inc. For: Oct 19
-
Form D Opus Databento CS LLC
-
Form 424B2 BANK OF MONTREAL /CAN/
-
Form 424B2 BANK OF MONTREAL /CAN/
-
Form NPORT-P Series Portfolios Trust For: Aug 31
-
Form 8-K BANK OF AMERICA CORP For: Oct 23
-
Form NPORT-P Series Portfolios Trust For: Aug 31
-
Form SCHEDULE 13G Nature's Miracle Holding Filed by: Adair Kathleen Theresa
-
Form 424B2 BANK OF MONTREAL /CAN/
-
Form 497 iShares, Inc.
-
Form 424B2 BANK OF MONTREAL /CAN/
